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Introduction
With the advent of microorganism identification via non-culture 
techniques, it is now well recognized that the upper respiratory 
tract as well as the the lower respiratory tract of healthy 
individuals is normally colonized by a large number of bacteria. 
The recognition of the lung microbiome indicates that several 
aspects of our traditional model of pneumonia pathogenesis 
were incorrect. In this commentary, I will speculate regarding 
the possible mechanisms of pneumonia pathogenesis. I will also 
contemplate the possibility that in some patients, an episode 
of acute pneumonia may evolve into a chronic subclinical 
pneumonia.
Traditional model of pneumonia 
pathogenesis
Our traditional approach to the pathogenesis of pneumonia 
was based on the wrong assumption that the alveoli were sterile 
(Figure 1.A). In this outdated model, the first step in the 
development of pneumonia was the arrival of bacteria to the 
alveoli (Figure 1.B). Once bacteria arrived to the alveoli, the 
next step was dependent of the interaction between invading 
bacteria and alveolar macrophages, with two possible outcomes. 
Alveolar macrophages may kill the bacteria, restoring the 
alveolar space to the normal sterile condition, or the bacteria 
may overcome alveolar macrophages and multiply in the 
alveolar space. In response to this uncontrolled bacterial 
multiplication, alveolar macrophages will produce cytokines, 
and the local and systemic inflammatory response characteristic 
of pneumonia will ensue (Figure 1.C). In this traditional model 
there was a single pathway for the development of pneumonia.
The lung microbiome
At the alveolar level, the lung microbiome is constituted primar-
ily of anaerobic organisms, with predominance of the phylum 
Bacteroidetes (1). Some microorganisms are living freely in the 
alveolar space, in a planktonic form, but half of the bacterial 
communities are attached to alveolar cells (2). It is likely that 
most of these organisms are living in cell-associated biofilm 
communities (Figure 2.A).
Figure 1. The sterile alveolus (1.A) and the traditional model of pneumonia 
pathogenesis with bacteria arriving and multiplying in the alveoli (1.B) and 
the development of a local inflammatory response (1.C).
New models of pneumonia pathogenesis
The pathogenesis of pneumonia may still involve the arrival of 
new bacteria into the alveolar space. Once these new bacteria ar-
rive to the alveoli, the interaction will be among the new bacte-
ria, the alveolar macrophages, and the alveolar microbiota. The 
newly arrived bacteria will need to overcome the alveolar mac-
rophages as well as the normal alveolar flora to be able to multi-
ply and cause pneumonia (Figure 2.B). If the lung microbiome 
is an integral part of the lung innate immunity, an abnormal 
alveolar microbiota, or dysbiosis, may be an important risk fac-
tor for the development of pneumonia. Prior antibiotic use may 
predispose to pneumonia by altering the alveolar microbiome.
As part of the pathogenesis of pneumonia, the need for the arrival 
of bacteria to the alveoli is not longer necessary, since bacteria, 
as well as viruses and fungi, are part of the normal alveolar 
microbiota. We can speculate that pneumonia may develop by 
the uncontrolled multiplication of some of the bacteria already 
present in the alveoli. In this model of pathogenesis, depicted in 
Figure 2.C, the etiologic agent of pneumonia will be bacteria 
that typically constitute the alveoli normal flora. This scenario 
may explain why in some patients with pneumonia an etiologic 
agent is not identified, since these bacteria can not be isolated 
using regular culture techniques.
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A final model of pathogenesis may include a combination of 
uncontrolled multiplication of new bacteria arriving to the 
alveoli associated to uncontrolled multiplication of some of 
the species present in the alveolar microbiota (Figure 2.D). In 
this type of pathogenesis, the etiology of pneumonia will be 
polymicrobial, with a combination of invading bacteria plus 
bacteria normally present in the alveoli.  
Figure 2. The lung microbiome (2.A) and three possible models 
for pneumonia pathogenesis (2.B, 2.C, and 2.D). 
A new respiratory infection: Chronic 
subclinical pneumonia
Persistent subclinical inflammation has been documented 
in some patients after clinical resolution of an episode of 
community-acquired pneumonia (3). These patients are at 
increased risk for cardiovascular events, rehospitalization, and 
mortality. The reason for this persistent lung inflammation is 
not clear. It can be speculated that current antibiotic therapy 
for pneumonia is able to kill invading microorganisms, but an 
abnormal alveolar microbiota may persist even after the patient 
is clinically cured. The persistent multiplication of some species 
belonging to the alveolar microbiota will set the stage for a 
subclinical respiratory infection associated to low level chronic 
lung inflammation, an entity that can be defined as chronic 
subclinical pneumonia. This unregulated lung inflammation 
may persist until the normal alveolar bacteria composition 
is restored. Therapeutic interventions aimed to restore 
homeostasis of the lung microbiome may be necessary to curtail 
chronic lung inflammation after an episode of pneumonia.
Conclusion
From all the ideas expressed in this opinion piece, we can be 
certain that our traditional model of pneumonia pathogenesis 
is incorrect. All other concepts regarding the role of the lung 
microbiome in the pathogenesis of acute pneumonia or the 
development of chronic subclinical pneumonia are only 
hypothesis that will need to be tested with further research. 
The lung microbiome has forced all investigators in the field of 
pneumonia to go back to the drawing board.
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